All news

75,000 Alto Neuroscience (ANRO) shares are proposed for sale by officer Michael Hanley.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Alto Neuroscience officer Michael Hanley has filed a notice for the proposed sale of 75,000 common shares, valued at $2,215,500, with an approximate sale date of November 16, 2026. The shares are to be acquired through stock-option exercises over the next three months. This transaction is being conducted under Rule 10b5-1, with a plan adoption date of August 14, 2026.

Read original source

ANRO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.